SEC Comment Letter for Genprex, Inc. (GNPX) (CIK 0001595248) (GNPX) — Oct 22, 2019

Genprex, Inc. (GNPX) (CIK 0001595248)
Date: Oct. 22, 2019 · CIK: 0001595248 · Accession: 0000000000-19-014766

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-38244

Date

October 22, 2019

Author

Ryan M. Confer

Form

UPLOAD

Company

Genprex, Inc. (GNPX) (CIK 0001595248)

Letter

October 22, 2019 Ryan M. Confer Chief Financial Officer Genprex, Inc. 1601 Trinity Street, Bldg B Suite 3.322 Austin, TX 78712 Re:Genprex, Inc. Form 10-K for the Fiscal Year Ended December 31, 2018 Filed April 1, 2019 Form 10-Q for the Quarterly Period Ended June 30, 2019 Filed August 13, 2019 File No. 001-38244 Dear Mr. Confer: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

October 22, 2019
Ryan M. Confer
Chief Financial Officer
Genprex, Inc.
1601 Trinity Street, Bldg B
Suite 3.322
Austin, TX 78712
Re:Genprex, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2018
Filed April 1, 2019
Form 10-Q for the Quarterly Period Ended June 30, 2019
Filed August 13, 2019
File No. 001-38244
Dear Mr. Confer:
            We have completed our review of your filings.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io